Simmunome

Montréal, Canada

Drug Discovery AI drug discovery Preclinical Development

We address the inefficiency of clinical trial success that is currently at >90% failure rate. Simmunome is at the leading edge of leveraging AI towards unraveling biological complexity. We transform physiological systems into biologically representative computational models for use in therapeutic and preventative drug discovery. Despite the significant technological advances in biotechnology, high-throughput methods, and computational biology over the last 20 years, it has proven difficult to gain meaningful insights that translate into truly disruptive medicines. We combine fragmented data to create holistic models of disease that translate to helping you understand your drug's mechanism of action, increase efficacy in the right target population and predict your drug's safety profile. Ultimately getting you to market faster, reducing your R&D costs, and dramatically increasing your probability of success.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Simmunome on @MedStartr Today #DrugDiscovery #DiseasePrevention #AllTherapeuticAreas #AIDrugDiscovery #PreclinicalDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/QnTHSUF3BEc

Get Involved in Simmunome

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2017
Website: www.simmunome.com/

Disease Areas

Drug Discovery Disease Prevention All Therapeutic Areas

Technologies

Computational BiologyComputational Drug DiscoveryIn Silico DesignAI Drug Discovery

🌐Website

What do you think of Simmunome?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.